Effect of plasmin on laminin and fibronectin during plasmin-assisted vitrectomy

Archives of Ophthalmology

Volumn 123, Issue 2, 2005, Pages 209-213

  Uemura, Ai ^a   Nakamura, Makoto ^a   Kachi, Shu ^a   Nishizawa, Yuji ^a   Asami, Tetsu ^a   Miyake, Yozo ^a   Terasaki, Hiroko ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; LAMININ; PLASMIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IN VITRO STUDY; LENS IMPLANT; MOLECULAR WEIGHT; PHACOEMULSIFICATION; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; RETINA MACULA HOLE; VITRECTOMY; VITREOUS BODY DETACHMENT; WESTERN BLOTTING;

BASEMENT MEMBRANE; BLOTTING, WESTERN; COMBINED MODALITY THERAPY; FIBRINOLYTIC AGENTS; FIBRONECTINS; HUMANS; LAMININ; MACULAR EDEMA, CYSTOID; PLASMIN; RETINAL PERFORATIONS; VITRECTOMY; VITREOUS BODY;

EID: 13244259215     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.123.2.209     Document Type: Article

References (30)

1. Tanaka M, Qui H. Pharmacological vitrectomy. Semin Ophthalmol. 2000;15:51-61.
2. Trese MT. Enzymatic-assisted vitrectomy. Eye. 2002;16:365-368.
3. Trese MT. Enzymatic vitreous surgery. Semin Ophthalmol. 2000;15:116-121.
4. Verstraeten TC, Chapman C, Hartzer M, Winkler BS, Trese MT, Williams GA. Pharmacologic induction of posterior vitreous detachment in the rabbit. Arch Ophthalmol. 1993;111:849-854.
5. Gandorfer A, Ulbig M, Kampic A. Plasmin-assisted vitrectomy eliminates cortical vitreous remnants. Eye. 2002;16:95-97.
6. Gandorfer A, Priglinger S, Schebitz K, et al. Vitreoretinal morphology of plasmin-treated human eyes. Am J Ophthalmol. 2002;133:156-159.
7. Li X, Shi X, Fan J. Posterior vitreous detachment with plasmin in the isolated human eye. Graefes Arch Clin Exp Ophthalmol. 2002;240:56-62.
8. Gandorfer A, Putz E, Welge-Lüssen U, Grüterich M, Ulbig M, Kampik A. Ultrastructure of the vitreoretinal interface following plasmin assisted vitrectomy. Br J Ophthalmol. 2001;85:6-10.
9. Asami T, Terasaki H, Kachi S, et al. Ultrastructure of internal limiting membrane removed during plasmin-assisted vitrectomy from eyes with diabetic macular edema. Ophthalmology. 2004;111:231-237.
10. Margherio AR, Margherio RR, Hartzer M, Trese MT, Williams GA, Ferrone PJ. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes. Ophthalmology. 1998;105:1617-1620.
11. Trese MT, Williams GA, Hartzer MK. A new approach to stage 3 macular holes. Ophthalmology. 2000;107:1607-1611.
12. Williams JG, Trese MT, Williams GA, Hartzer MK. Autologous plasmin enzyme in the surgical management of diabetic retinopathy. Ophthalmology. 2001; 108:1902-1906.
13. Liotta LA, Goldfarb RH, Brundage R, Siegal GP, Terranova V, Garbisa S. Effect of plasminogen activator (urokinase), plasmin, and thrombin on glycoprotein and collagenous components of basement membrane. Cancer Res. 1981;41:4629-4636.
14. Liotta LA, Goldfarb RH, Terranova VP. Cleavage of laminin by thrombin and plasmin: alpha thrombin selectively cleaves the beta chain of laminin. Thromb Res. 1981;21:663-673.
15. Kohno T, Sorgente N, Ishibashi T, Goodnight R, Ryan SJ. Immunofluorescent studies of fibronectin and laminin in the human eye. Invest Ophthalmol Vis Sci. 1987;28:506-514.
16. Kohno T, Sorgente N, Goodnight R, Ryan SJ. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophthalmol Vis Sci. 1987;28:515-521.
17. Scheiffarth OF, Kampik A, Günther H, von der Mark K. Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch Clin Exp Ophthalmol. 1988; 226:357-361.
18. Stenman S, Vaheri A. Distribution of a major connective tissue protein, fibronectin, in normal human tissues. J Exp Med. 1978;147:1054-1064.
19. Engvall E, Ruoslahti E, Miller EJ. Affinity of fibronectin to collagens of different genetic types and to fibrinogen. J Exp Med. 1978;147:1584-1595.
20. Foidart JM, Bere EW Jr, Yaar M, et al. Distribution and immunoelectron microscopic localization of laminin, a noncollagenous basement membrane glycoprotein. Lab Invest. 1980;42:336-342.
21. Terranova VP, Rohrbach DH, Martin GR. Role of laminin in the attachment of PAM 212 (epithelial) cells to basement membrane collagen. Cell. 1980;22: 719-726.
22. Terranova VP, Liotta LA, Russo RG, Martin GR. Role of laminin in the attachment and metastasis of murine tumor cells. Cancer Res. 1982;42:2265-2269.
23. Yurchenco PD, Schittny JC. Molecular architecture of basement membranes. FASEB J. 1990;4:1577-1590.
24. Leblond CP, Inoue S. Structure, composition, and assembly of basement membrane. Am J Anat. 1989;185:367-390.
25. Kohno T, Sorgente N, Patterson R, Ryan SJ. Fibronectin and laminin distribution in bovine eye. Jpn J Ophthalmol. 1983;27:496-505.
26. Goldfinger LE, Stack MS, Jones JC. Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol. 1998;141:255-265.
27. Balian G, Click EM, Crouch E, Davidson JM, Bornstein P. Isolation of a collagen-binding fragment from fibronectin and cold-insoluble globulin. J Biol Chem. 1979; 254:1429-1432.
28. Balian G, Click EM, Bornstein P. Location of a collagen-binding domain in fibronectin. J Biol Chem. 1980;255:3234-3236.
29. Hikichi T, Yanagiya N, Kado M, Akiba J, Yoshida A. Posterior vitreous detachment induced by injection of plasmin and sulfur hexafluoride in the rabbit vitreous. Retina. 1999;19:55-58.
30. Beck K, Hunter I, Engel J. Structure and function of laminin: anatomy of a multidomain glycoprotein. FASEB J. 1990;4:148-160.